ReP USP - Resultado da busca

Artigo de periodico
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial (2022)
Sekine, Leo ; Arns, Beatriz ; Fabro, Bruna R.; Cipolatt, Murillo M.; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz
Source: European Respiratory Journal. Unidade: ICB
Subjects: MICROBIOLOGIA, PLASMA, COVID-19, ESTUDOS RANDOMIZADOS, IMUNIZAÇÃO PASSIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEKINE, Leo et al. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. European Respiratory Journal, v. 59, n. 2, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1183/13993003.02076-2021. Acesso em: 16 nov. 2024.
APA
Sekine, L., Arns, B., Fabro, B. R., Cipolatt, M. M., Machado, R. R. G., & Durigon, E. L. (2022). Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. European Respiratory Journal, 59( 2), 1-11. doi:10.1183/13993003.02076-2021
NLM
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial [Internet]. European Respiratory Journal. 2022 ; 59( 2): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1183/13993003.02076-2021
Vancouver
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial [Internet]. European Respiratory Journal. 2022 ; 59( 2): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1183/13993003.02076-2021
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Source: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subjects: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 16 nov. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico
Cold atmospheric pressure plasma is effective against P. gingivalis (HW24D-1) mature biofilms and non-genotoxic to oral cells (2022)
Lima, Gabriela de Morais Gouvêa ; Carta, Celina Faig Lima; Borges, Aline Chiodi ; Nishime, Thalita Mayumi Castaldelli ; Silva, Cézar Augusto Villela da ; Caliari, Marcelo Vidigal ; Mayer, Marcia Pinto Alves ; Kostov, Konstantin Georgiev ; Ito, Cristiane Yumi Koga
Source: Applied Sciences. Unidade: ICB
Subjects: MICROBIOLOGIA, PORPHYROMONAS GINGIVALIS, GENÉTICA ODONTOLÓGICA, BACTÉRIAS ANAERÓBICAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, PERIODONTITE, PLASMA, BIOFILMES, PRESSÃO ATMOSFÉRICA, PERIODONTO DE PROTEÇÃO, CISTO PRIMORDIAL, DANO AO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Gabriela de Morais Gouvêa et al. Cold atmospheric pressure plasma is effective against P. gingivalis (HW24D-1) mature biofilms and non-genotoxic to oral cells. Applied Sciences, v. 12, n. 14, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/app12147247. Acesso em: 16 nov. 2024.
APA
Lima, G. de M. G., Carta, C. F. L., Borges, A. C., Nishime, T. M. C., Silva, C. A. V. da, Caliari, M. V., et al. (2022). Cold atmospheric pressure plasma is effective against P. gingivalis (HW24D-1) mature biofilms and non-genotoxic to oral cells. Applied Sciences, 12( 14), 1-11. doi:10.3390/app12147247
NLM
Lima G de MG, Carta CFL, Borges AC, Nishime TMC, Silva CAV da, Caliari MV, Mayer MPA, Kostov KG, Ito CYK. Cold atmospheric pressure plasma is effective against P. gingivalis (HW24D-1) mature biofilms and non-genotoxic to oral cells [Internet]. Applied Sciences. 2022 ; 12( 14): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/app12147247
Vancouver
Lima G de MG, Carta CFL, Borges AC, Nishime TMC, Silva CAV da, Caliari MV, Mayer MPA, Kostov KG, Ito CYK. Cold atmospheric pressure plasma is effective against P. gingivalis (HW24D-1) mature biofilms and non-genotoxic to oral cells [Internet]. Applied Sciences. 2022 ; 12( 14): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/app12147247
Artigo de periodico
Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 (2022)
Botosso, Viviane Fongaro ; Jorge, Soraia Attie Calil; Astray, Renato Mancini ; Guimarães, Ana Marcia de Sá ; Mathor, Monica Beatriz ; Carneiro, Patrícia dos Santos de; Durigon, Edison Luiz ; Covas, Dimas ; Durigon, Danielle Bruna Leal de Oliveira
Source: Scientific Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, IMUNOGLOBULINAS, HAMSTERS, PLASMA DE ANIMAL, MODELOS ANIMAIS DE DOENÇAS, CORONAVIRUS, PLASMA, ANTÍGENOS DE VÍRUS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOTOSSO, Viviane Fongaro et al. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Scientific Reports, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-07793-1. Acesso em: 16 nov. 2024.
APA
Botosso, V. F., Jorge, S. A. C., Astray, R. M., Guimarães, A. M. de S., Mathor, M. B., Carneiro, P. dos S. de, et al. (2022). Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Scientific Reports, 12, 1-17. doi:10.1038/s41598-022-07793-1
NLM
Botosso VF, Jorge SAC, Astray RM, Guimarães AM de S, Mathor MB, Carneiro P dos S de, Durigon EL, Covas D, Durigon DBL de O. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-022-07793-1
Vancouver
Botosso VF, Jorge SAC, Astray RM, Guimarães AM de S, Mathor MB, Carneiro P dos S de, Durigon EL, Covas D, Durigon DBL de O. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-022-07793-1
Artigo de periodico
Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19 (2021)
Lazari, Lucas Cardoso ; Ghilardi, Fabio De Rose ; Fernandes, Livia Rosa ; Assis, Diego M. ; Nicolau, José Carlos ; Santiago, Veronica Feijoli ; Dalçóquio, Talia Falcão; Pascale, Claudia Blanes Angeli ; Bertolin, Adriadne Justi ; Marinho, Claudio Romero Farias ; Wrenger, Carsten ; Durigon, Edison Luiz ; Siciliano, Rinaldo Focaccia ; Palmisano, Giuseppe
Source: Life Science Alliance. Unidades: FM, ICB
Subjects: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, ESPECTROMETRIA DE MASSAS, PLASMA, TRANSTORNOS DAS PROTEÍNAS SANGUÍNEAS, AMILOIDOSE, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAZARI, Lucas Cardoso et al. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19. Life Science Alliance, v. 4, n. 8, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.26508/lsa.202000946. Acesso em: 16 nov. 2024.
APA
Lazari, L. C., Ghilardi, F. D. R., Fernandes, L. R., Assis, D. M., Nicolau, J. C., Santiago, V. F., et al. (2021). Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19. Life Science Alliance, 4( 8), 1-12. doi:10.26508/lsa.202000946
NLM
Lazari LC, Ghilardi FDR, Fernandes LR, Assis DM, Nicolau JC, Santiago VF, Dalçóquio TF, Pascale CBA, Bertolin AJ, Marinho CRF, Wrenger C, Durigon EL, Siciliano RF, Palmisano G. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19 [Internet]. Life Science Alliance. 2021 ; 4( 8): 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.26508/lsa.202000946
Vancouver
Lazari LC, Ghilardi FDR, Fernandes LR, Assis DM, Nicolau JC, Santiago VF, Dalçóquio TF, Pascale CBA, Bertolin AJ, Marinho CRF, Wrenger C, Durigon EL, Siciliano RF, Palmisano G. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19 [Internet]. Life Science Alliance. 2021 ; 4( 8): 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.26508/lsa.202000946
Artigo de periodico
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing (2021)
Mendrone Junior, Alfredo ; Dinardo, Carla Luana ; Ferreira, Suzete Cleuza ; Nishya, Anna ; Salles, Nanci Alves; Almeida Neto, Cesar de ; Hamasaki, Debora Toshei; Facincani, Tila ; Alves, Lucas Bassolli de Oliveira ; Machado, Rafael Rahal Guaragna ; Araujo, Danielle Bastos ; Durigon, Edison Luiz ; Rocha, Vanderson Geraldo ; Sabino, Ester Cerdeira
Source: Transfusion. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, COVID-19, IMUNOENSAIO, IMUNOGLOBULINAS, ANTICORPOS, TESTES IMUNOLÓGICOS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDRONE JUNIOR, Alfredo et al. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16268. Acesso em: 16 nov. 2024.
APA
Mendrone Junior, A., Dinardo, C. L., Ferreira, S. C., Nishya, A., Salles, N. A., Almeida Neto, C. de, et al. (2021). Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, 10 . doi:10.1111/trf.16268
NLM
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16268
Vancouver
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16268
Artigo de periodico
Anti‐A and SARS‐CoV‐2: an intriguing association (2021)
Dutra, Valeria de Freitas ; Bub, Carolina Bonet ; Yokoyama, Ana Paula Hitomi ; Achkar, Ruth; Machado, Rafael Rahal Guaragna ; Assunção, Murilo; Candelelaria, Gabriela; Soares, Camila Pereira ; Fachini, Roberta Maria; Wendel, Rita Fontão; Hamerschlak, Nelson ; Reis, Luiz Fernando Lima; Araujo, Danielle Bastos ; Nudelman, Victor ; Pinho, João R. R. ; Rizzo, Luiz Vicente ; Sakashita, Araci M. ; Scuracchio, Patrícia; Durigon, Edison Luiz ; Wendel, Silvano ; Kutner, José Mauro
Source: Vox Sanguinis. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, GRUPOS SANGUÍNEOS, INFECÇÕES POR CORONAVIRUS, PLASMA, REAÇÃO EM CADEIA POR POLIMERASE, IMUNOGLOBULINAS, ESTUDOS DE COORTES, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUTRA, Valeria de Freitas et al. Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, p. 7 , 2021Tradução . . Disponível em: https://doi.org/10.1111/vox.13044. Acesso em: 16 nov. 2024.
APA
Dutra, V. de F., Bub, C. B., Yokoyama, A. P. H., Achkar, R., Machado, R. R. G., Assunção, M., et al. (2021). Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, 7 . doi:10.1111/vox.13044
NLM
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/vox.13044
Vancouver
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/vox.13044
Artigo de periodico
Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? (2021)
Wendel, Silvano ; Fachini, Roberta ; Wendel, Rita C. L. Fontão; Santos, Ralyria Mello Vieira dos ; Velasquez, Carlos Vinícius; Machado, Rafael Rahal Guaragna ; Brito, Mayra Altobelli; Amaral, Marcelo; Soares, Camila Pereira ; Achkar, Ruth; Scuracchio, Patrícia ; Miyaji, Sandra Cristina; Erdens, Melina Santos; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIVIRAIS, COVID-19, DOADORES DE SANGUE, TESTES SOROLÓGICOS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?. Transfusion, v. 61, n. 12, p. 3455-3467, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16714. Acesso em: 16 nov. 2024.
APA
Wendel, S., Fachini, R., Wendel, R. C. L. F., Santos, R. M. V. dos, Velasquez, C. V., Machado, R. R. G., et al. (2021). Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? Transfusion, 61( 12), 3455-3467. doi:10.1111/trf.16714
NLM
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16714
Vancouver
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16714
Artigo de periodico
Cold atmospheric plasma jet as a possible adjuvant therapy for periodontal disease (2021)
Lima, Gabriela de Morais Gouvêa ; Borges, Aline Chiodi ; Nishime, Thalita Mayumi Castaldelli ; Melo, Gabriela de Fatima Santana ; Kostov, Konstantin Georgiev ; Mayer, Marcia Pinto Alves ; Ito, Cristiane Yumi Koga
Source: Molecules. Unidade: ICB
Subjects: MICROBIOLOGIA, DOENÇAS PERIODONTAIS, ANTI-INFLAMATÓRIOS, DOENÇAS PERIODONTAIS, RESISTÊNCIA MICROBIANA ÀS DROGAS, PORPHYROMONAS GINGIVALIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, STREPTOCOCCUS, QUIMIOTERAPIA ADJUVANTE, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Gabriela de Morais Gouvêa et al. Cold atmospheric plasma jet as a possible adjuvant therapy for periodontal disease. Molecules, v. 26, n. 18, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26185590. Acesso em: 16 nov. 2024.
APA
Lima, G. de M. G., Borges, A. C., Nishime, T. M. C., Melo, G. de F. S., Kostov, K. G., Mayer, M. P. A., & Ito, C. Y. K. (2021). Cold atmospheric plasma jet as a possible adjuvant therapy for periodontal disease. Molecules, 26( 18), 1-14. doi:10.3390/molecules26185590
NLM
Lima G de MG, Borges AC, Nishime TMC, Melo G de FS, Kostov KG, Mayer MPA, Ito CYK. Cold atmospheric plasma jet as a possible adjuvant therapy for periodontal disease [Internet]. Molecules. 2021 ; 26( 18): 1-14.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/molecules26185590
Vancouver
Lima G de MG, Borges AC, Nishime TMC, Melo G de FS, Kostov KG, Mayer MPA, Ito CYK. Cold atmospheric plasma jet as a possible adjuvant therapy for periodontal disease [Internet]. Molecules. 2021 ; 26( 18): 1-14.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/molecules26185590
Artigo de periodico
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections (2021)
Wendel, Silvano ; Wendel, Rita Fontão; Fachini, Roberta; Candelaria, Gabriela ; Scuracchio, Patricia; Achkar, Ruth; Brito, Mayra; Reis, Luiz Fernando ; Camargo, Anamaria ; Amano, Mariane ; Machado, Rafael Rahal Guaragna ; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, SANGUE, PLASMA, COVID-19, ESTUDOS LONGITUDINAIS, CINÉTICA QUÍMICA, ANTICORPOS, REAÇÃO EM CADEIA POR POLIMERASE, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, p. 14 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16323. Acesso em: 16 nov. 2024.
APA
Wendel, S., Wendel, R. F., Fachini, R., Candelaria, G., Scuracchio, P., Achkar, R., et al. (2021). A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, 14 . doi:10.1111/trf.16323
NLM
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16323
Vancouver
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16323
Artigo de periodico
COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes (2021)
Yokoyama, Ana Paula Hitomi ; Wendel, Silvano ; Bub, Carolina Bonet ; Fachini, Roberta M.; Dametto, Ana Paula F.; Blumm, Fernando; Dutra, Valeria F. ; Candelaria, Gabriela T. P. ; Sakashita, Araci M.; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Hamerschlak, Nelson ; Achkar, Ruth; Assunção, Murillo Santucci Cesar ; Scuracchio, Patrícia; Nudelman, Victor; Pastore, Laerte; Pinho, João R. R.; Ben, Mirian Dal; Kalil Filho, Roberto ; Marra, Alexandre R.; Amano, Mariane T. ; Kallás, Esper Georges ; Helito, Alfredo Salim; Carvalho, Carlos Roberto Ribeiro De ; Araujo, Danielle Bastos ; Durigon, Edison Luiz ; Camargo, Anamaria Aranha ; Rizzo, Luiz V. ; Reis, Luiz F. L. ; Kutner, José Mauro
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, COVID-19, TRANSFUSÃO DE SANGUE, PLASMA, ANTICORPOS, ESTUDOS DE COORTES, PACIENTES, UNIDADES DE TERAPIA INTENSIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOKOYAMA, Ana Paula Hitomi et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16573. Acesso em: 16 nov. 2024.
APA
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Blumm, F., et al. (2021). COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, 1-12. doi:10.1111/trf.16573
NLM
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16573
Vancouver
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16573
Artigo de periodico
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program (2020)
Wendel, Silvano ; Kutner, José Mauro ; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Bub, Carolina ; Fachini, Roberta; Yokoyama, Ana ; Candelaria, Gabriela ; Sakashita, Araci ; Achkar, Ruth; Hamerschlak, Nelson ; Scuracchio, Patricia; Amaral, Marcelo; Ben, Mirian Dal; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Camargo, Anamaria ; Kallás, Esper Georges ; Durigon, Edison Luiz ; Reis, Luiz Fernando ; Rizzo, Luiz Vicente
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, IMUNOTERAPIA, PLASMA, ANTICORPOS, TRIAGEM, REAÇÃO EM CADEIA POR POLIMERASE, ADJUVANTES IMUNOLÓGICOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, p. 1-4, 2020Tradução . . Disponível em: https://doi.org/10.1111/trf.16065. Acesso em: 16 nov. 2024.
APA
Wendel, S., Kutner, J. M., Machado, R. R. G., Wendel, R. F., Bub, C., Fachini, R., et al. (2020). Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, 1-4. doi:10.1111/trf.16065
NLM
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16065
Vancouver
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/trf.16065
Artigo de periodico
Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa (2020)
Silva, Rafael Trivella Pacheco da; Petri, Marcos Vinícius ; Morante, Estela Ynés Valencia ; Camargo, Pedro Henrique Cury de ; Torresi, Susana Inês Córdoba de ; Spira, Beny
Source: Photodiagnosis and Photodynamic Therapy. Unidades: IQ, ICB
Subjects: MICROBIOLOGIA, PSEUDOMONAS, NANOPARTÍCULAS, OXIGÊNIO, RESISTÊNCIA MICROBIANA ÀS DROGAS, PLASMA, CITOMETRIA DE FLUXO, ANTIBIÓTICOS, ÍONS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rafael Trivella Pacheco da et al. Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa. Photodiagnosis and Photodynamic Therapy, v. 31, p. 7 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pdpdt.2020.101908. Acesso em: 16 nov. 2024.
APA
Silva, R. T. P. da, Petri, M. V., Morante, E. Y. V., Camargo, P. H. C. de, Torresi, S. I. C. de, & Spira, B. (2020). Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa. Photodiagnosis and Photodynamic Therapy, 31, 7 . doi:10.1016/j.pdpdt.2020.101908
NLM
Silva RTP da, Petri MV, Morante EYV, Camargo PHC de, Torresi SIC de, Spira B. Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 31 7 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.101908
Vancouver
Silva RTP da, Petri MV, Morante EYV, Camargo PHC de, Torresi SIC de, Spira B. Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 31 7 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.101908
Artigo de periodico
Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients (2019)
Barbosa, Flavia Hebeler ; Massolini, Viviam Milanez ; Watanabe, Thais ; Silva, Giovanni Faria ; Barbosa, Alexandre Naime ; Simões, Rafael Plana ; Ferrasi, Adriana Camargo ; Zanotto, Paolo Marinho de Andrade ; Pardini, Maria Inês de Moura Campos ; Grotto, Rejane Maria Tommasini
Source: Medicine. Unidade: ICB
Subjects: MICROBIOLOGIA, HIV, INFECÇÕES POR HIV, RNA VIRAL, PLASMA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Flavia Hebeler et al. Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients. Medicine, p. 6 , 2019Tradução . . Disponível em: https://doi.org/10.1097/MD.0000000000016376. Acesso em: 16 nov. 2024.
APA
Barbosa, F. H., Massolini, V. M., Watanabe, T., Silva, G. F., Barbosa, A. N., Simões, R. P., et al. (2019). Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients. Medicine, 6 . doi:10.1097/MD.0000000000016376
NLM
Barbosa FH, Massolini VM, Watanabe T, Silva GF, Barbosa AN, Simões RP, Ferrasi AC, Zanotto PM de A, Pardini MI de MC, Grotto RMT. Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients [Internet]. Medicine. 2019 ; 6 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/MD.0000000000016376
Vancouver
Barbosa FH, Massolini VM, Watanabe T, Silva GF, Barbosa AN, Simões RP, Ferrasi AC, Zanotto PM de A, Pardini MI de MC, Grotto RMT. Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients [Internet]. Medicine. 2019 ; 6 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/MD.0000000000016376
Trabalho de evento-resumo periodico
Comparison of three methods for analysing fluoride in microlitre-volume plasma samples (2018)
Zohoori, Fatemeh Vida ; Martinez-Mier, A.; Maguire, A.; Buzalaf, Marília Afonso Rabelo ; Sanderson, R.; Eckert, G. J.
Source: Caries Research. Conference titles: ORCA Congress. Unidade: FOB
Subjects: CÁRIE DENTÁRIA, FLÚOR, MICROBIOLOGIA, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZOHOORI, Fatemeh Vida et al. Comparison of three methods for analysing fluoride in microlitre-volume plasma samples. Caries Research. Basel: Faculdade de Odontologia de Bauru, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000488302. Acesso em: 16 nov. 2024. , 2018
APA
Zohoori, F. V., Martinez-Mier, A., Maguire, A., Buzalaf, M. A. R., Sanderson, R., & Eckert, G. J. (2018). Comparison of three methods for analysing fluoride in microlitre-volume plasma samples. Caries Research. Basel: Faculdade de Odontologia de Bauru, Universidade de São Paulo. doi:10.1159/000488302
NLM
Zohoori FV, Martinez-Mier A, Maguire A, Buzalaf MAR, Sanderson R, Eckert GJ. Comparison of three methods for analysing fluoride in microlitre-volume plasma samples [Internet]. Caries Research. 2018 ; 52 513.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1159/000488302
Vancouver
Zohoori FV, Martinez-Mier A, Maguire A, Buzalaf MAR, Sanderson R, Eckert GJ. Comparison of three methods for analysing fluoride in microlitre-volume plasma samples [Internet]. Caries Research. 2018 ; 52 513.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1159/000488302

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration